Occlusion-2 (HERO-2) trial, V 1 ST levels were analyzed with adjustment for lead V 3 ST level for predicting 30-day mortality. V 1 ST elevation at baseline, analyzed as a continuous variable, was associated with higher mortality. Unadjusted, each 0.5-mm-step increase in ST level above the isoelectric level was associated with Ϸ25% increase in 30-day mortality; this was true whether V 3 ST depression was present or not. The odds ratio for mortality was 1.21 (95% confidence interval, 1.07 to 1.37) after adjustment for inferolateral ST elevation and clinical factors and 1.24 (95% confidence interval, 1.09 to 1.40) if also adjusted for V 3 ST level. In contrast, lead V 1 ST depression was not associated with mortality after adjustment for V 3 ST level. V 1 ST elevation Ն1 mm, analyzed dichotomously in all patients, was associated with higher mortality. 
T he concept of ST elevation acute myocardial infarction (AMI) originated from animal studies, with ST-segment elevation on the epicardial leads correlating with ST elevation on body surface ECG leads. 1 Lead V 1 directly faces the right ventricle and during an inferior AMI may exhibit ST elevation with concomitant right ventricular infarction. Lead V 1 also faces the endocardial surface of the posterolateral left ventricle, and ST depression may reflect concomitant posterolateral infarction (as the "mirror image" of ST elevation involving posterolateral epicardial leads). Both right ventricular infarction and posterolateral infarction worsen the prognosis of an inferior AMI. [2] [3] [4] 
Clinical Perspective on p 469
The precordial ST depression associated with transmural posterolateral AMI is generally more pronounced in leftsided chest leads V 2 and V 3 than in the right-sided chest lead V 1 . Because lead V 3 does not directly face the right ventricle, ST changes in V 3 reflect predominantly left rather than right ventricular pathologies. In lead V 1 , however, ST elevation from right ventricular AMI may potentially cancel out the ST depression from posterolateral AMI to give an isoelectric ST level. Diagnosis of right ventricular infarction during an inferior AMI may therefore be aided by evaluating both V 1 and V 3 ST levels. The prognostic meaning of V 1 ST elevation and its serial changes after fibrinolysis is not well defined despite the otherwise wealth of literature on ST resolution in AMI. [5] [6] [7] [8] [9] Therefore, we evaluated the prognostic value of V 1 ST elevation in patients with inferior AMI from the Hirulog and Early Reperfusion or Occlusion-2 (HERO-2) trial, which included 17 073 patients with ST-elevation AMI. Patients were randomized within 6 hours of symptom onset to receive bivalirudin or heparin in addition to streptokinase and aspirin. The randomized treatments had no effect on the primary end point of 30-day mortality. 10 The trial protocol specified recording serial ECGs at randomization and 60 minutes after streptokinase was begun. [11] [12] [13] [14] [15] [16] 
Methods
The protocol and results of the HERO-2 trial have been reported. 10 Patients who presented with Ͼ30 minutes of ischemic chest pain and either ST-segment elevation or presumed new left bundle-branch block within 6 hours of symptom onset were randomized to receive bivalirudin or unfractionated heparin in addition to streptokinase and aspirin. All ECGs were sent to the core laboratory at Green Lane Hospital for analysis by 8 ECG technicians [11] [12] [13] [14] [15] [16] who were unaware of treatment assignment and patient outcomes.
ECG Analysis
The present analysis of ST changes in lead V 1 was performed only in patients with inferior AMI showing normal intraventricular conduction at both randomization and the 60-minute time point. The amount of ST-segment change, for both elevation and depression, was measured to the nearest 0.5 mm at 60 milliseconds after the J point for all 12 standard leads on both ECGs by a team of 8 experienced technicians. [11] [12] [13] [14] [15] [16] Inferior AMI was diagnosed from ECG changes of Ն1-mm ST elevation in 2 adjacent inferior leads. Patients with concomitant ST elevation involving 2 adjacent leads in both the anterior territory and inferior territory were classified as having anterior AMI.
Statistical Analysis
On a normality test, the distributions of age, systolic and diastolic blood pressures, pulse rate, summed ST depression, and summed ST elevation were skewed. For consistency, all continuous variables are therefore reported as the median and 25th and 75th percentiles and compared by the Mann-Whitney U test or Kruskal-Wallis test when appropriate. Discrete variables are presented as percentages, and the 2 test was used for comparison.
The primary analysis examined the relationship between ST elevation in lead V 1 on the baseline ECG and 30-day mortality. Exploratory analysis was performed stratified according to clinically relevant ST depression cut points in lead V 3 (V 3 ST level at or above Ϫ0.5 mm, V 3 ST level of Ϫ1 or Ϫ1.5 mm, V 3 ST level of Ϫ2 mm or below).
Multivariable logistic regression analysis incorporated summed baseline ST-segment elevation (inferior leads II, III, and aVF and lateral leads V 5 , V 6 , I, and aVL) and other clinical prognostic factors in the HERO-2 cohort. [11] [12] [13] [14] [15] [16] These included age and sex, systolic blood pressure, Killip class, heart rate, history of previous AMI, diabetes mellitus, hypertension, prior angina, time from symptom onset to randomization, and geographic region of patient recruitment. The V 1 ST level was explored both as a continuous variable per each step of 0.5-mm change from the isoelectric 0-mm level and as a dichotomous variable using clinically relevant ST level cut points of 0.5 or 1 mm. In the latter analyses, interaction terms between the dichotomously defined V 1 ST elevation and V 3 ST level were tested. Further analysis was performed among patients with V 1 ST elevation to ascertain whether the persistence of V 1 ST elevation in the first hour after fibrinolytic therapy was related to 30-day mortality.
Results
This analysis included 7967 patients with inferior AMI and normal intraventricular conduction at randomization and at 60 minutes as shown in the Figure. In lead V 1 , 1874 patients had ST elevation Ն0.5 mm (749 with 0.5 mm, 619 with 1 mm, and 506 with Ն1.5 mm), 2213 patients had isoelectric (0 mm) ST level, and 3880 had ST depression with ST level Յ0.5 mm. 4 ST depression (0.5 versus 1.5 mm; PϽ0.001). At 30 days, mortality was higher in patients with V 1 ST elevation compared with patients without V 1 ST elevation (7.6% versus 5.2%; PϽ0.002). Compared with patients with isoelectric (0 mm) ST levels, patients with V 1 ST depression also had worse baseline characteristics and higher 30-day mortality (7.6% versus 5.2%; PϽ0.001). Among patients with isoelectric or positive ST levels, 30-day mortality increased with increasing V 1 ST elevation (5.2% with 0 mm, 6.4% with 0.5 mm, 6.8% with 1 mm, and 10.3% with Ն1.5 mm; P for trend Ͻ0.001). Table 2 shows the relationship between V 1 ST segment level (as elevation, isoelectric, or depression) and 30-day mortality in subgroups (columns) according to V 3 ST depression stratified into 3 levels (rows). The lowest mortality of 4.3% was observed in the 1374 patients with V 1 ST level of 0 mm and no V 3 ST depression.
Baseline Characteristics

Relationship Between V 1 ST Level and 30-Day Mortality
The majority of patients with ST depression in V 1 also had ST depression in V 3 , and only 507 patients (6.4%) had V 1 ST elevation concomitant with V 3 ST depression of Ն1 mm. In these 507 patients, 30-day mortality was 9.9% compared with 6.8% in the 839 patients who had a similar degree of V 3 ST depression but an isoelectric (0 mm) V 1 ST level (Pϭ0.048).
V 3 ST Depression and Mortality
Examination of lead V 3 ST level in the whole cohort shows that those with ST depression of Ն1 mm had higher mortality than those without ST depression (7.9% versus 5.8%; (Table 3) . Unadjusted, each 0.5-mm-step increase in V 1 ST level above 0 mm (ie, ST elevation) was associated with an Ϸ25% increase in 30-day mortality. This was true for all V 3 level subgroups. In the whole cohort, the final odds ratio after adjustment for inferolateral ST elevation and clinical factors was 1.21 (95% confidence interval, 1.07 to 1.37) and 1.24 (95% confidence interval, 1.09 to 1.40) when adjusted also for V 3 ST level. In contrast, each 0.5-mm-step decrease in V 1 ST level below 0 mm was not significantly associated with 30-day mortality after adjustment for V 3 ST level.
PϽ0.001).
Significance of V1 ST Elevation Using Dichotomous Cut Points
V 1 ST elevation Ն1 mm was significantly associated with higher 30-day mortality (28% higher unadjusted, 51% higher if adjusted for V 3 ST level, 51% higher if adjusted for both V 3 ST level and inferolateral ST elevation, and 35% higher after further adjustment for all clinical factors; Table 4 ). The C index of the full algorithm was 0.82. Findings were similar, albeit to a lesser extent, when the V 1 ST elevation cut point of 0.5 mm was used ( Table 4 ). The interaction term (V 1 ST elevation times V 3 ST level) was not significant in both analyses (Pϭ0.293 for 1-mm V 1 ST cut point, Pϭ0.392 for 0.5-mm V 1 ST cut point). 6 , I, and aVL) leads. †Clinical factors included age and sex, systolic blood pressure, Killip class, heart rate, history of previous AMI, diabetes mellitus, hypertension, prior angina, time from symptom onset to randomization, and geographic region of patient recruitment.
‡Adjusted also for V 3 ST level.
Persistence of Lead V 1 ST Elevation After Fibrinolysis
Among patients with V 1 ST elevation, those with persistent elevation in lead V 1 at 60 minutes after fibrinolysis was started were associated with higher mortality than those who had V 1 ST elevation resolved. This was true regardless of whether the ST cut point was 1 mm (10.8% versus 5.5%; Pϭ0.001) or 0.5 mm (9.1% versus 4.4%; PϽ0.001; Table 5 ).
Discussion
This study in 7967 patients with acute inferior AMI showed that lead V 1 ST elevation is a marker of increased 30-day mortality independently of the extent of inferolateral ST elevation, V 3 ST depression, and clinical parameters. In this cohort, 1874 patients (23.5%) had V 1 ST elevation Ն0.5 mm and 1125 (14.1%) had V 1 ST elevation Ն1 mm. Consistent with the finding that V 1 ST elevation conferred a worse prognosis, there was a lower mortality among patients who had V 1 ST elevation resolved than those with persistent V 1 ST elevation at 60 minutes after administration of fibrinolytic therapy.
Patients with V 1 ST depression also had higher mortality than those with isoelectric V 1 ST level. This is consistent with the literature on the negative prognostic effects associated with precordial ST depression. Thus, V 1 ST deviation in both directions was analyzed in subgroups according to V 3 ST level (Tables 2 and 3) , and the prognostic effect of V 1 ST elevation was analyzed with V 3 ST level as a cofactor in multivariable regression. The new finding was an association between a 0.5-mm-step increase in V 1 ST elevation (referenced to 0-mm ST level) and higher 30-day mortality that was independent of V 3 ST level.
Further to the higher mortality found in patients with V 3 ST depression compared with patients without V 3 ST depression, the present study shows that most patients with V 1 ST depression also have ST depression in lead V 3 . The odds ratio for 30-day mortality of a 0.5-mm-step increase in V 1 ST depression below 0 mm was almost 1 when the analysis was adjusted for V 3 ST segment level, suggesting that the prognostic information of V 1 ST depression did not add further to V 3 ST depression. This finding is consistent with the notion that ST depression from concomitant posterolateral infarction is often better seen in left-sided lead V 3 than in right-sided lead V 1 .
In the entire 7967 patient cohort and with the use of dichotomous cut points, V 1 ST elevation Ն1 mm predicted a 28% higher unadjusted 30-day mortality and a 51% higher adjusted 30-day mortality when ECG factors were added. The serial adjustment process, as reported in Table 4 , showed that the odds ratio increased after adjustment for V 3 ST level.
The relative importance of right ventricular and posterolateral infarction to mortality with V 1 ST elevation cannot be directly determined in this study because data on imaging of the right ventricle and LV were not available. The poor prognosis with right ventricular infarction has previously been reported, both in patients receiving fibrinolytic therapy 2, 17, 18 and in patients having primary percutaneous coronary intervention. 19 We speculate that because the normal right ventricle contains much less myocardial mass than the left ventricle, infarction of the majority of the right ventricular myocardium could significantly increase the mortality of patients with an acute inferior AMI with a relatively small increase in infarct mass. This contrasts with concomitant infarction of the posterolateral left ventricular wall, which significantly increases both total infarct mass and mortality. The present study shows the negative prognostic value of V 1 ST elevation independently of and adding to the other negative prognostic ECG sign of V 3 ST depression, which reflects posterolateral infarction.
The ECG diagnosis of right ventricular infarction is classically made by recording lead V 4 R. In an autopsy study of 43 patients, ST elevation in lead V 4 R had higher sensitivity and specificity than ST elevation in lead V 1 in diagnosing right ventricular infarction. 20 Similarly, ST elevation in leads V 7 through V 9 adds significantly to precordial ST depression in aiding the diagnosis of posterolateral AMI. [21] [22] [23] However, recording leads V 4 R and V 7 through V 9 is an additional step in the performance of a standard 12-lead ECG and, although recommended, 24, 25 may not be routinely performed.
Recording lead V 1 in the right parasternal position might capture the ST elevation from right ventricular infarction in more patients during the acute phase of AMI. Indeed, the prognostic role of V 4 R recordings relative to V 1 recordings in patients receiving prompt reperfusion therapy needs to be studied. Standard 12-lead ECGs are increasingly being performed before hospitalization 26 to enable shorter times to the administration of fibrinolytic therapy or to balloon inflation for primary percutaneous coronary intervention. The availability of pocket-size ECG machines capable of networking through cell phones will likely make this even more common. The present study supports the use of information from the readily available V 1 recordings to aid risk stratification and prognostication.
Limitations
We have correlated 30-day mortality with V 1 ST elevation, which we judged to be likely due to right ventricular infarction, but we acknowledge that there was no imaging confirmation. Despite careful adjustment of the V 3 ST level, the possibility exists that in some patients, concomitant right ventricular and posterolateral infarctions might have ST elevation forces cancelling out ST depression forces over both precordial leads V 1 and V 3 .
Statistical adjustment for multiple testing was not undertaken. However, the observation of consistent results with different ST segment cut levels and with different adjustments for other ECG and clinical variables in several exploratory analyses strengthens the conclusions of this article.
A number of factors other than myocardial ischemia and infarction influence V 1 ST level. 27 High ST-segment takeoff in the V 1 through V 3 precordial chest leads occurs up to 1.5 mm in female and up to 2 mm in male patients. 27 ST elevation is often more pronounced in V 2 and V 3 than in V 1 , 27 causing diagnostic difficulties, particularly in patients with anterior AMI, and could be a confounding factor in assessing precordial ST levels in patients with inferior AMI. In the HERO-2 trial, most patients had cardiac biomarker elevation confirming the diagnosis of AMI. 10 The present study did not include any patients with concomitant anterior ST elevation affecting Ͼ1 chest lead because they would not have been classified as having an inferior AMI.
Lead placement position can also affect ST level measurements, but leads V 1 and V 2 , in the right and left parasternal positions, respectively, are the most reproducible of the 6 chest lead positions. Lead V 1 can be regarded as lead V 2 R, and our analysis defines the prognostic meaning of rightsided ST elevation during inferior AMI in a large patient population database.
Conclusions
In this study of 7967 patients with inferior AMI, ST elevation in V 1 at baseline had incremental adverse prognostic significance that was independent of the effect of precordial V 3 ST depression. Resolution of V 1 ST elevation after fibrinolysis was associated with improved 30-day survival, lending further support to the independent prognostic value of this simple ECG parameter. We speculate that the mechanistic link between V 1 elevation and increased mortality is due to the occurrence of right ventricular infarction.
